Skip to main content

Hudson Bay Capital Management LP

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1393825 STAMFORD, CT

Position in AUPH

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,259,700
-$96,050 QoQ
Shares Held
85,000
0.0% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Derivatives in AUPH

reported options exposure · as of Dec 31, 2022
CallValue
$432,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in AUPH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,259,700 85,000
2025-12-31 $1,355,750 85,000
2025-03-31 $804,000 100,000
2024-12-31 $763,300 85,000
2024-09-30 $2,052,400 280,000
2024-06-30 $1,940,829 339,900
2024-03-31 $1,454,904 290,400
2023-12-31 $831,575 92,500
2023-09-30 $1,215,880 156,484
2023-06-30 $1,272,765 131,484
2023-03-31 $2,646,664 241,484
2022-12-31 $1,648,010 381,484
2022-12-31 $432,000 100,000
2022-09-30 $752,000 100,000
2022-09-30 $2,366,423 314,684
2022-06-30 $1,773,664 176,484
2022-06-30 $1,005,000 100,000
2022-03-31 $1,999,171 161,484
2022-03-31 $1,238,000 100,000
2021-12-31 $2,277,852 99,600
2021-06-30 $8,229,600 635,000
2021-03-31 $10,063,375 775,000
2020-12-31 $9,681,000 700,000
2020-09-30 $8,175,150 555,000
2020-06-30 $6,093,750 375,000
2020-03-31 $5,949,100 410,000